Market closedNon-fractional
Akoya BioSciences/AKYA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Akoya BioSciences
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Ticker
AKYA
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Marlborough, United States
Employees
330
Website
www.akoyabio.com
AKYA Metrics
BasicAdvanced
$121M
Market cap
-
P/E ratio
-$1.44
EPS
1.52
Beta
-
Dividend rate
Price and volume
Market cap
$121M
Beta
1.52
Financial strength
Current ratio
3.068
Quick ratio
2.261
Long term debt to equity
250.026
Total debt to equity
260.331
Interest coverage (TTM)
-5.99%
Management effectiveness
Return on assets (TTM)
-22.59%
Return on equity (TTM)
-181.72%
Valuation
Price to revenue (TTM)
1.229
Price to book
3.7
Price to tangible book (TTM)
-54.05
Price to free cash flow (TTM)
-2.068
Growth
Revenue change (TTM)
17.89%
Earnings per share change (TTM)
-25.04%
3-year revenue growth (CAGR)
28.96%
3-year earnings per share growth (CAGR)
-49.49%
What the Analysts think about AKYA
Analyst Ratings
Majority rating from 8 analysts.
AKYA Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$18M
-30.68%
Net income
-$23M
116.67%
Profit margin
-127.86%
212.62%
AKYA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.51
-$0.26
-$0.22
-$0.48
-
Expected
-$0.44
-$0.37
-$0.27
-$0.29
-$0.27
Surprise
15.16%
-28.91%
-18.08%
66.23%
-
AKYA News
AllArticlesVideos
Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
GlobeNewsWire·2 weeks ago
Lab Instrument Industry Update - New Commercial Entrants
Seeking Alpha·2 months ago
Akoya Biosciences, Inc. (AKYA) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Akoya BioSciences stock?
Akoya BioSciences (AKYA) has a market cap of $121M as of July 27, 2024.
What is the P/E ratio for Akoya BioSciences stock?
The price to earnings (P/E) ratio for Akoya BioSciences (AKYA) stock is 0 as of July 27, 2024.
Does Akoya BioSciences stock pay dividends?
No, Akoya BioSciences (AKYA) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Akoya BioSciences dividend payment date?
Akoya BioSciences (AKYA) stock does not pay dividends to its shareholders.
What is the beta indicator for Akoya BioSciences?
Akoya BioSciences (AKYA) has a beta rating of 1.52. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Akoya BioSciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.